Concepedia

Publication | Closed Access

Angiotensin II up‐regulates PAX2 oncogene expression and activity in prostate cancer via the angiotensin II type I receptor

25

Citations

28

References

2009

Year

Abstract

Therefore, PAX2 may be a novel therapeutic target for the treatment of carcinomas such as prostate cancer via the down-regulation of its expression by targeting the AT1R signaling pathways.

References

YearCitations

Page 1